Alpha-GPC
CholinergicAlso known as: Alpha-glycerophosphocholine · L-Alpha glycerylphosphorylcholine · choline alfoscerate
A highly bioavailable choline compound that crosses the blood-brain barrier. Studied for cognitive enhancement, memory, and as a growth hormone secretagogue. Used in Europe for Alzheimer's treatment.
How expert claims hold up
52 of 52 claims assessed4 of 52 assessed claims supported or partially supported by published research
Expert Consensus
Dose divergence: Experts recommend different amounts (600milligrams, 300-600milligrams). Check the Stack & Timing tab for study-backed dosing ranges.
Evidence Summary
The available evidence for Alpha-GPC (l-α-glycerylphosphorylcholine) as a cognitive supplement is limited based on the two studies reviewed here. A review article acknowledges Alpha-GPC's therapeutic potential for mental health-related disorders and age-related neurodegeneration, and notes it has received safety approvals and is gaining market attention in the food industry. However, the only randomized controlled trial included did not directly test Alpha-GPC — it examined choline from egg yolk — making it difficult to draw firm conclusions about Alpha-GPC specifically from this evidence set alone. The RCT was a randomized, double-blinded, placebo-controlled trial in healthy middle-aged and older Japanese adults examining the effects of egg yolk choline on cognitive function and plasma choline levels. While this study design is methodologically sound, its relevance to Alpha-GPC is indirect at best, since egg yolk choline and Alpha-GPC are different compounds with potentially different bioavailability and mechanisms. The review article provides broader context about Alpha-GPC's regulatory status and market prospects, but reviews are inherently lower in the evidence hierarchy than well-powered clinical trials. Both studies are rated as moderate quality. Several important caveats apply. Neither study directly compares Alpha-GPC to placebo in a controlled trial measuring cognitive outcomes, which is the gold standard needed to support efficacy claims. The claim that Alpha-GPC is among the 'more evidence-supported' cognitive supplements cannot be verified from this literature set alone. Key unknowns include optimal dosing for healthy adults, long-term safety at supplemental doses, and whether cognitive benefits observed in clinical populations (e.g., Alzheimer's patients) translate to healthy individuals. Consumers should be aware that marketing claims about Alpha-GPC often outpace the available direct clinical evidence.
Read full evidence summary →Top studies
Effects of egg yolk choline intake on cognitive functions and plasma choline levels in healthy middle-aged and older Japanese: a randomized double-blinded placebo-controlled parallel-group study.
Effects of egg yolk choline intake on cognitive functions and plasma choline levels in healthy middle-aged and older Japanese: a randomized double-blinded placebo-controlled parallel-group study.
Unlocking the potential of l-α-glycerylphosphorylcholine in the food industry: From safety approvals to market prospects.
Unlocking the potential of l-α-glycerylphosphorylcholine in the food industry: From safety approvals to market prospects.
Expert Mentions
All 52 mentions
“there's a study suggesting that long-term high-dose choline supplementation may increase TMAO — trimethylamine N-oxide — production, which has been associated with cardiovascular risk. This is controversial and the magnitude of risk from supplemental doses isn't clear, but it's something to be aware of.”
A study suggests that long-term high-dose choline supplementation may increase TMAO production, which has been associated with cardiovascular risk, though the magnitude of risk from supplemental doses is unclear.
Neither of the two provided studies directly addresses the relationship between high-dose choline supplementation, TMAO production, and cardiovascular risk. The first study (PMID: 37340479) is an RCT…
“there's a study suggesting that long-term high-dose choline supplementation may increase TMAO — trimethylamine N-oxide — production, which has been associated with cardiovascular risk. This is controversial and the magnitude of risk from supplemental doses isn't clear, but it's something to be aware of.”
A study suggests that long-term high-dose choline supplementation may increase TMAO production, which has been associated with cardiovascular risk, though the magnitude of risk from supplemental doses is unclear.
Neither of the two provided studies directly addresses the relationship between choline supplementation, TMAO production, and cardiovascular risk. The first study (PMID: 37340479) is an RCT examining…
Safety, interactions & who should avoid Alpha-GPC
generally_recognized_safe
The review article notes that Alpha-GPC has received safety approvals supporting its use in food and supplement contexts, suggesting it is considered generally safe at studied doses. However, the reviewed literature does not provide detailed long-term safety data specifically for supplemental use in healthy adults.
Alpha-GPC is generally considered well-tolerated in the doses studied; a safety review notes it has received regulatory approvals in several markets, but long-term safety data in healthy populations remains limited. Some users report mild GI discomfort or headaches.
Who should avoid it
Individuals taking anticholinergic drugs should use caution; those with known hypersensitivity to choline-based compounds should avoid use. Pregnant or breastfeeding individuals and those with liver conditions should consult a healthcare provider before use.
Known interactions
- ·May interact with anticholinergic medications by opposing their mechanism of action
- ·Potential additive effects when combined with other cholinergic compounds or acetylcholinesterase inhibitors
Pregnancy & breastfeeding
Our sources specifically flag pregnancy or breastfeeding considerations for Alpha-GPC — see the cautions above.
We don’t assign pregnancy-safety ratings. Many supplements lack adequate safety data in pregnancy and breastfeeding, and the absence of a warning here does not mean a supplement is safe to take. Don’t start, stop, or continue any supplement while pregnant or nursing without your OB-GYN or midwife.
Read: Supplements during pregnancy & breastfeeding →This is educational information only. Consult a healthcare provider before starting any supplement.
Stay on top of Alpha-GPC research
One email a month when new research on Alpha-GPC is published.
Double opt-in · unsubscribe anytime · not medical advice.
No buy link — yet
We only link products that meet our sourcing standards. We haven’t linked one for Alpha-GPC yet. Our standards →
Key findings
- ·A review article identifies Alpha-GPC (l-α-GPC) as having demonstrated therapeutic potential for mental health and age-related neurodegenerative conditions, though the strength of underlying trials is not detailed in this summary.
- ·Alpha-GPC has received regulatory safety approvals and is being considered for broader use in the food industry, suggesting an acceptable short-term safety profile at studied doses.
- ·An RCT in healthy middle-aged and older Japanese adults studied egg yolk choline — not Alpha-GPC directly — limiting its direct applicability to Alpha-GPC supplementation.
Evidence gaps
- ·No direct placebo-controlled RCT testing Alpha-GPC supplementation in healthy adults for cognitive outcomes is included in this evidence set, making efficacy claims in healthy populations unverifiable from these studies.
- ·The translation of findings from clinical populations (e.g., Alzheimer's patients) to healthy individuals seeking cognitive enhancement remains unestablished based on the available literature.
- ·Long-term safety data at commonly marketed supplemental doses of Alpha-GPC in healthy adults is not addressed by the studies reviewed.